PDS Biotechnology PDSB
NASDAQ PDSB
$0.22 +0.01 (+4.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Property, Plant & Equipment (Net) (2014 - 2026)

PDS Biotechnology (PDSB) Property, Plant & Equipment (Net) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 PDS Biotechnology 12.02 Mn 12.02 Mn - 176,612.00

Historic Data

Download Data
DateValue
Jun 30, 2026 176,612.00
Jun 30, 2026 176,612.00
Dec 31, 2025 120,184.00
Dec 31, 2025 120,184.00
Sep 30, 2025 125,643.00
Sep 30, 2025 125,643.00
Jun 30, 2025 131,102.00
Jun 30, 2025 131,102.00
Mar 31, 2025 136,561.00
Mar 31, 2025 136,561.00
Dec 31, 2024 142,020.00
Dec 31, 2024 142,020.00
Sep 30, 2024 147,479.00
Sep 30, 2024 147,479.00
Jun 30, 2024 152,938.00
Jun 30, 2024 152,938.00
Mar 31, 2024 129,398.00
Mar 31, 2024 129,398.00
Dec 31, 2023 134,132.00
Dec 31, 2023 134,132.00